Overexpression of MDM2 was frequently observed in various types of cancers, such as osteosarcoma, rhabdomyosarcoma, and fibrosarcoma,21, 22 and it was usually associated with poor prognosis. Here, MDM2 is linked to rhabdomyosarcoma.